The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCURAY INC | COM | 004397105 | 14,163 | 1,475,360 | SH | SOLE | 1,475,360 | 0 | 0 | ||
ACHAOGEN INC | COM | 004449104 | 10,106 | 653,700 | SH | SOLE | 653,700 | 0 | 0 | ||
ACTAVIS PLC | SHS | G0083B108 | 50,721 | 246,398 | SH | SOLE | 246,398 | 0 | 0 | ||
AFFYMETRIX INC | COM | 00826T108 | 96 | 13,500 | SH | SOLE | 13,500 | 0 | 0 | ||
AGILENT TECHNOLOGIES INC | COM | 00846U101 | 43,226 | 772,994 | SH | SOLE | 772,994 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 15,258 | 294,612 | SH | SOLE | 294,612 | 0 | 0 | ||
ALLERGAN INC | COM | 018490102 | 222 | 1,786 | SH | SOLE | 1,786 | 0 | 0 | ||
AMBIT BIOSCIENCES CORP | COM | 02318X100 | 3,353 | 367,602 | SH | SOLE | 367,602 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 17,588 | 8,496,538 | SH | SOLE | 8,496,538 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 22,950 | 4,882,930 | SH | SOLE | 4,882,930 | 0 | 0 | ||
BIOSPECIFICS TECHNOLOGIES CO | COM | 090931106 | 7,040 | 271,620 | SH | SOLE | 271,620 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 21,741 | 418,500 | SH | SOLE | 418,500 | 0 | 0 | ||
CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 12,450 | 391,627 | SH | SOLE | 391,627 | 0 | 0 | ||
CASTLIGHT HEALTH INC | CL B | 14862Q100 | 20,826 | 1,184,347 | SH | SOLE | 1,184,347 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM | 15117B103 | 15,266 | 863,947 | SH | SOLE | 863,947 | 0 | 0 | ||
CERUS CORP | COM | 157085101 | 2,814 | 586,205 | SH | SOLE | 586,205 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 20,442 | 895,006 | SH | SOLE | 895,006 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 35,549 | 513,198 | SH | SOLE | 513,198 | 0 | 0 | ||
CYNOSURE INC | CL A | 232577205 | 586 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 7,584 | 598,077 | SH | SOLE | 598,077 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 10,233 | 795,095 | SH | SOLE | 795,095 | 0 | 0 | ||
FLEXION THERAPEUTICS INC | COM | 33938J106 | 8,113 | 493,183 | SH | SOLE | 493,183 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM | 372427104 | 2,278 | 125,244 | SH | SOLE | 125,244 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 4,405 | 2,117,555 | SH | SOLE | 2,117,555 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 28,264 | 1,062,952 | SH | SOLE | 1,062,952 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 19,211 | 323,583 | SH | SOLE | 323,583 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 815 | 64,167 | SH | SOLE | 64,167 | 0 | 0 | ||
HCA HOLDINGS INC | COM | 40412C101 | 45,811 | 872,589 | SH | SOLE | 872,589 | 0 | 0 | ||
HEALTHWAYS INC | COM | 422245100 | 23,222 | 1,354,832 | SH | SOLE | 1,354,832 | 0 | 0 | ||
HEARTWARE INTL INC | COM | 422368100 | 27,381 | 291,974 | SH | SOLE | 291,974 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 4,980 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 7,610 | 460,923 | SH | SOLE | 460,923 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 21,673 | 457,048 | SH | SOLE | 457,048 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 16,857 | 51,113 | SH | SOLE | 51,113 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 18,199 | 1,001,060 | SH | SOLE | 1,001,060 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 19,815 | 142,886 | SH | SOLE | 142,886 | 0 | 0 | ||
KYTHERA BIOPHARMACEUTICALS I | COM | 501570105 | 17,627 | 443,326 | SH | SOLE | 443,326 | 0 | 0 | ||
MARKET VECTORS ETF TR | BIOTECH ETF | 57060U183 | 292 | 3,208 | SH | SOLE | 3,208 | 0 | 0 | ||
MARKET VECTORS ETF TR | PHARMACEUTICAL | 57060U217 | 379 | 6,500 | SH | SOLE | 6,500 | 0 | 0 | ||
MODEL N INC | COM | 607525102 | 8,638 | 854,378 | SH | SOLE | 854,378 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 10,905 | 528,070 | SH | SOLE | 528,070 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 20,023 | 521,301 | SH | SOLE | 521,301 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 13,892 | 1,090,428 | SH | SOLE | 1,090,428 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 692 | 19,374 | SH | SOLE | 19,374 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 12,541 | 624,869 | SH | SOLE | 624,869 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 11,712 | 452,194 | SH | SOLE | 452,194 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 21,439 | 559,611 | SH | SOLE | 559,611 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 17,922 | 172,092 | SH | SOLE | 172,092 | 0 | 0 | ||
RECEPTOS INC | COM | 756207106 | 13,032 | 310,727 | SH | SOLE | 310,727 | 0 | 0 | ||
RITE AID CORP | COM | 767754104 | 23,837 | 3,801,800 | SH | SOLE | 3,801,800 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM NEW | 867328601 | 66 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 33,801 | 789,562 | SH | SOLE | 789,562 | 0 | 0 | ||
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 39,171 | 297,136 | SH | SOLE | 297,136 | 0 | 0 | ||
VOCERA COMMUNICATIONS INC | COM | 92857F107 | 2,832 | 173,408 | SH | SOLE | 173,408 | 0 | 0 | ||
XOMA CORP DEL | COM | 98419J107 | 7,932 | 1,522,543 | SH | SOLE | 1,522,543 | 0 | 0 |